BIO 2026 Sends a Biotech Warning: U.S. Sense of Urgency Becomes an Industry Competitiveness Issue
As new drugs, manufacturing, and biosecurity are all folded into national competition, the biotech industry’s anxiety is no longer just about a funding winter, but whether institutions can keep pace with the speed of science.